Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Non-Moderated Poster Abstract
Eposter Presentation
Eposter in PDF Format
https://storage.unitedwebnetwork.com/files/1237/e5316686add1b52c119641f635ecadbc.pdf
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
https://storage.unitedwebnetwork.com/files/1237/61c1ea19f861ea2bcce716e4055ada5e.png
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
The effect of tyrosine kinase inhibitors toxic to male fertility in patients with chronic myeloid leukemia and the efficacy of sperm cryopreservation.
Presentation Type
Non-Moderated Poster Abstract
Manuscript Type
Clinical Research
Abstract Category *
Andrology: Male Infertility/ Male Hypogonadism
Author's Information
Number of Authors (including submitting/presenting author) *
8
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
Japan
Co-author 1
Shinnosuke Kuroda shin1014@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan *
Co-author 2
Teppei Takeshima teppei_t@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan -
Co-author 3
Jurii Karibe juriikaribe@gmail.com Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan -
Co-author 4
Tomoki Saito tomokisaito@hotmail.co.jp Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan -
Co-author 5
Kota Shimokihara shimokihara.kot.bf@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan -
Co-author 6
Takashi Kawahara kawahara@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology and Renal Transplantation Yokohama Japan -
Co-author 7
Junichi Teranishi jteran@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology and Renal Transplantation Yokohama Japan -
Co-author 8
Yasushi Yumura yumura@yokohama-cu.ac.jp Yokohama City University Medical Center Department of Urology, Center for Reproductive Medicine Yokohama Japan -
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
Chronic myeloid leukemia (CML) is a relatively slowly progressing blood disease, and its prognosis has been improved in recent years due to advances in molecular-targeted drugs, especially tyrosine kinase inhibitors (TKIs). On the other hand, some cases require allogeneic transplantation due to blast crisis. The effect or toxicity of molecular target drugs such as TKIs to male fertility are still unclear. We retrospectively investigated the effects of the drugs to male fertility and usage of cryopreserved semen in cases where sperm was frozen for treatment of CML at our hospital.
Materials and Methods
We have reviewed 20 male patients with CML who have visited our reproduction center for sperm cryopreservation between February 2013 and March 2025. The used drugs for treatments, the change in semen analyses, and the usage of cryopreserved sperm were retrospectively investigated.
Results
The age of the 20 cases was 30.8 years (19-47). TKIs (nilotinib, dazatinib, and/or bonatinib) were used in 17 cases while antimetabolites and cytotoxic anticancer drugs were used in the other cases. In 10 cases where TKIs were used, semen analysis was performed at least once during follow-up after cryopreservation. The average of duration between cryopreservation and the latest follow-up semen analysis was 6.5±4.7 years. Among five patients who have been using TKI, there was no significant decline in semen parameters. The amount of change (Δ) of concentration and motility between first and the latest semen analyses were +6.2±26.2 million/mL and -9.6±21.8%, respectively. On the other hand, azoospermia persisted in all five cases who underwent allogeneic transplantation. Cryopreserved sperm was used in three cases, and pregnancies and live birth were achieved with intracytoplasmic sperm injection and embryo transfer. On the other hand, two cases have achieved pregnancy and live birth spontaneously during CML treatment with TKIs.
Conclusions
The toxicity of TKIs to male fertility was not significant in the follow-up semen analyses. On the other hand, the cases who underwent allogeneic transplantation revealed prolonged azoospermia. Cryopreserved semen was utilized to achieve successful pregnancy and live birth in such cases. Thus, fertility preservation is still important for CML patients.
Keywords
Male Infertility, Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia, Sperm Cryopreservation
Figure 1
Figure 1 Caption
Figure 2
Figure 2 Caption
Figure 3
Figure 3 Caption
Figure 4
Figure 4 Caption
Figure 5
Figure 5 Caption
Character Count
1909
Vimeo Link
Presentation Details
Session
Date
Time
Presentation Order
0